Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Autonomix, we¿re developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain.
| Last: | $0.43 |
|---|---|
| Change Percent: | 1.87% |
| Open: | $0.402 |
| Close: | $0.4221 |
| High: | $0.44 |
| Low: | $0.402 |
| Volume: | 210,228 |
| Last Trade Date Time: | 02/27/2026 12:38:50 pm |
| Market Cap: | $2,866,686 |
|---|---|
| Float: | 6,479,402 |
| Insiders Ownership: | 0.07% |
| Institutions: | 7 |
| Short Percent: | N/A |
| Industry: | Medical Equipment & Supplies |
| Sector: | Healthcare |
| Website: | https://www.autonomix.com |
| Country: | US |
| City: | The Woodlands |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Autonomix Medical Inc. (NASDAQ: AMIX).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
